ADM plans to expand NovaLipid™ production
To add capacity at its Mankato, Minnesota enzyme interesterification facility.
21/03/05 Archer Daniels Midland Company will expand NovaLipid™ production by adding capacity at its Mankato, Minnesota enzyme interesterification facility.
NovaLipid™ products are the Company’s line of zero/low trans-fat oils and margarines. Construction is scheduled to be completed late in 2005. This is the second expansion to the NovaLipid line. Last year, the Company had announced that it was expanding its production at its Quincy, Illinois facility to help satisfy the food industry’s demands as it moves forward to meet the January 1, 2006, FDA labeling requirement1.
The Food and Drug Administration (FDA) has announced changes to the Nutritional Labeling Education Act that will require the labeling of trans-fats on all nutritional fact panels by January 1, 2006.
Archer Daniels Midland Company (ADM) is a world leader in agricultural processing. ADM is one of the world's largest processors of soybeans, corn, wheat and cocoa. ADM is also a leader in the production of soy meal and oil, ethanol, corn sweeteners and flour. In addition, ADM produces value-added food and feed ingredients. Headquartered in Decatur, Illinois, ADM has over 26,000 employees, more than 250 processing plants and net sales for the fiscal year ended June 30, 2004 of $36.2 billion.
Upcoming webinars
The new math of functional eating in the GLP-1 era: addressing texture, nutrients, and health
Jungbunzlauer
The No-Compromise Formula: Ensuring Superior Taste in Nutrition-Focused Formulations
Biospringer by Lesaffre
All about Cococa Butter Equivalents
AAK
